Edwards Lifesciences Shares Fall as Heart-Valve Growth Slows
Edwards Lifesciences has slightly raised its annual forecasts for sales and profit, but slower-than-expected revenue growth in the company's artificial heart valves dragged its shares down.
Reuters Health Information
source https://www.medscape.com/s/viewarticle/994850?src=rss
Reuters Health Information
source https://www.medscape.com/s/viewarticle/994850?src=rss
Comments
Post a Comment